-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Guided Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Guided Therapeutics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$561K, a 9.95% increase year-over-year.
- Guided Therapeutics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$2.06M, a 47.4% increase year-over-year.
- Guided Therapeutics Inc annual Operating Income (Loss) for 2023 was -$3.46M, a 3.72% decline from 2022.
- Guided Therapeutics Inc annual Operating Income (Loss) for 2022 was -$3.33M, a 41.1% decline from 2021.
- Guided Therapeutics Inc annual Operating Income (Loss) for 2021 was -$2.36M, a 125% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)